Fluoroquinolone utilization in the emergency departments of academic medical centers: prevalence of, and risk factors for, inappropriate use.
about
Unnecessary use of fluoroquinolone antibiotics in hospitalized patientsUrinary Tract Infections: Leading Initiatives in Selecting Empiric Outpatient Treatment (UTILISE).Gastrointestinal tract colonization with fluoroquinolone-resistant Escherichia coli in hospitalized patients: changes over time in risk factors for resistance.Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired Pneumonia in adultsFlashes, floaters, and oral fluoroquinolones: is retinal detachment a worry?A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.Current ciprofloxacin usage in children hospitalized in a referral hospital in Paris[Thoracic manifestation of tuberculosis].Fluoroquinolone prescriptions in a teaching hospital: a prospective audit.An antimicrobial stewardship program with a focus on reducing fluoroquinolone overuse.[Evaluation of antibiotic prescriptions in the Emergency Department of the Military Hospital of Instruction Mohammed V (HMIMV)].Adverse reactions to fluoroquinolones in the Nigerian population: an audit of reports submitted to the National Pharmacovigilance Centre from 2004 to 2016.Drug use evaluation of moxifloxacin (avelox) using a hand-held electronic device at a canadian teaching hospital.Preferential Use of Nitrofurantoin Over Fluoroquinolones for Acute Uncomplicated Cystitis and Outpatient Escherichia coli Resistance in an Integrated Healthcare System.Antibiotic resistance of urinary pathogens in female general practice patients.Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study.Utilization, Spending, and Price Trends for Quinolones in the US Medicaid Programs: 25 Years’ Experience 1991–2015.Healthcare utilization and expenditures for United States Medicare beneficiaries with systemic vasculitis.Increase in antimicrobial resistance in bacteria isolated from stranded marine mammals of the Northwest Atlantic.
P2860
Q27496669-09138C3F-8FB2-416C-8B0E-919E6E6C335EQ33553121-D8B5222C-C15B-436D-A13A-0D31258F2D0AQ33905604-9102BDF5-9EB7-4F85-A306-4EEB4565E66EQ34077164-C9A5DC3B-B1E1-4925-B570-CBBC2FBB9C01Q34281801-08CC972F-6583-4755-9914-30792108B03AQ34611874-E546EB34-89DF-460A-9410-966A924CBB84Q34741643-BF2393C8-35B5-4447-9134-97C6B8B48A2FQ36136201-82B28F2D-3B9C-4753-9593-E15AFF9E0252Q36939682-59560592-5619-4590-A182-62D617C50029Q37498877-A7F26EFA-FD8D-47B8-8E26-BCDD4774137AQ37666651-9E66490A-4E29-4016-AA21-05C9DB3180CBQ37724289-0061D724-AF42-4FD2-A06B-EB1FF79D91E1Q40055329-44E6227D-DFB2-4FF1-9E77-34ECB622BF79Q40432811-C336A013-3D1C-4982-8283-F8BD16117B51Q43751271-946CD148-098B-48C8-A939-733FF1C6FBC6Q46943794-44B24265-A956-4834-8531-37AC05776716Q47117956-44B3C73A-F430-4ED2-B7E2-66A3C81B72E5Q47767132-408843D0-5D9A-4E06-84A4-0C8069F46026Q54312091-804C04BB-CBBB-4FE4-B02F-6FEABFBB618A
P2860
Fluoroquinolone utilization in the emergency departments of academic medical centers: prevalence of, and risk factors for, inappropriate use.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Fluoroquinolone utilization in ...... actors for, inappropriate use.
@ast
Fluoroquinolone utilization in ...... actors for, inappropriate use.
@en
Fluoroquinolone utilization in ...... actors for, inappropriate use.
@nl
type
label
Fluoroquinolone utilization in ...... actors for, inappropriate use.
@ast
Fluoroquinolone utilization in ...... actors for, inappropriate use.
@en
Fluoroquinolone utilization in ...... actors for, inappropriate use.
@nl
prefLabel
Fluoroquinolone utilization in ...... actors for, inappropriate use.
@ast
Fluoroquinolone utilization in ...... actors for, inappropriate use.
@en
Fluoroquinolone utilization in ...... actors for, inappropriate use.
@nl
P2093
P1476
Fluoroquinolone utilization in ...... actors for, inappropriate use.
@en
P2093
Ebbing Lautenbach
Helen P Peng
Lori A Larosa
Neil O Fishman
Nishaminy Kasbekar
Richard J Maniglia
P304
P356
10.1001/ARCHINTE.163.5.601
P407
P577
2003-03-01T00:00:00Z